NIRV.CN
Nirvana Life Sciences Inc
Price:  
0.08 
CAD
Volume:  
65,140.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NIRV.CN WACC - Weighted Average Cost of Capital

The WACC of Nirvana Life Sciences Inc (NIRV.CN) is 14.5%.

The Cost of Equity of Nirvana Life Sciences Inc (NIRV.CN) is 16.35%.
The Cost of Debt of Nirvana Life Sciences Inc (NIRV.CN) is 5.00%.

Range Selected
Cost of equity 14.70% - 18.00% 16.35%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 13.1% - 15.9% 14.5%
WACC

NIRV.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 2.27 2.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 14.70% 18.00%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.18 0.18
Cost of debt 5.00% 5.00%
After-tax WACC 13.1% 15.9%
Selected WACC 14.5%